Juris Bundulis
Juris Bundulis is the Chairman of the Board of Olpha, a pharmaceutical company focused on developing and registering new generic medications. He emphasizes the importance of local pharmaceutical production in enhancing price competition and improving patient access to healthcare.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Latvia:
Juris Bundulis is the chairman of the board of 'Olpha'.
8
Latvia:
Juris Bundulis, the chairman of the board of Olpha, indicates that each new local company's patent-free medication creates price competition and increases patient accessibility.
8